Heron Therapeutics Inc. News
Heron Shares Rise on Phase III Results of Agent Used in Knee Replacements
Study results show 75% of knee-replacement patients were discharged from the hospital without a prescription for opioids.
Sustainable Turn or Head Fake?: Cramer's 'Mad Money' Recap
Jim Cramer asks, 'What's it going to take to get rid of these sellers?' Keep an eye on the VIX and volume, he says.
Fifth Third Bancorp, Realty Income: 'Mad Money' Lightning Round
Jim Cramer weighs in on Fifth Third Bancorp, Realty Income, KLX Energy Services, STMicroelectronics, Heron Therapeutics, LKQ Corp. and more.
Here's why investors should steer clear of opioids
Backed by the government, initiatives to develop and popularize non-opioid painkillers can make investors high on profits.
Biotech Stock Mailbag: Heron, Acadia, Exact Sciences, Sarepta
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Heron Therapeutics (HRTX) Stock Advancing on Positive Analyst Note
Shares of Heron Therapeutics (HRTX) are rising after JMP Securities increased its price target to $33 from $25 while maintaining its 'outperform' rating.
Treasury Yields Jump After Weak $43 Billion 2-Year Auction, Sliding Foreign Demand
The Treasury sold $43 billion in 2-year notes at a high yield of 4.29% - nearly a full percentage point above last month's auction levels.
Economist El-Erian Sees Strong Chance for Recession
But he thinks the Fed must keep raising interest rates to quell inflation. And he expects continued market volatility.
Pound Collapse Puts Dollar Parity, Emergency Bank of England Rate Hikes in Focus
Britain's new government said it will continue focusing on tax cuts and new borrowing to boost growth even as markets push the pound to a record low against the U.S. dollar.
What Happens to Your Credit Card When Interest Rates Rise
With interest rates soaring, credit card consumers may be in for a shock